Related Articles
EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases
EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy
Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors
Predicting brain metastases of breast cancer based on serum S100B and serum HER2
Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue